Home Drug Codes C Codes C9155 · EPKINLY
Updated July 1st, 2026

EPKINLY C Code: C9155

Injection, epcoritamab-bysp, 0.16 mg

Login to unlock all benchmarks
Medicare Payment Limit ?
Not published
CMS publishes none for Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
No current ASP
Not available for Q3 2026
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
2
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, epcoritamab-bysp, 0.16 mg
HCPCS Added Date October 1, 2023
Manufacturer Genmab
Route of Administration Subcutaneous
Generic Status HCPCS Discontinued
Dosage Type Single-Dose
Dosage Form Injection, Solution

About EPKINLY

Epkinly is a medication aligned to the HCPCS C Code: C9155 for billing, pricing, and reimbursement purposes in the United States. It is an Oncology drug administered via the subcutaneous route and manufactured by Genmab.

Manufacturers, reach out to us to add more information.

NDC Code Information

2 NDC packages are crosswalked to C9155. Package detail is available to logged-in subscribers.

Login to view 2 NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

EPKINLY CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96401 Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic
96402 Chemotherapy administration, subcutaneous or intramuscular; hormonal anti-neoplastic
Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

EPKINLY Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Diffuse large B-cell lymphoma (DLBCL) or High-grade B-cell lymphoma Follicular Lymphoma
Drug Class
Bispecific CD20-directed CD3 T Cell Engager [EPC]CD20-directed Antibody Interactions [MoA]CD3 Receptor Agonists [MoA]CD3-directed Antibody Interactions [MoA]Cytochrome P450 Inhibitors [MoA]Increased Cytokine Activity [PE]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Epkinly billing and coding guide?
Our team has not identified a manufacturer-published source of billing and coding information for EPKINLY.
Are there any available Epkinly patient assistance programs?
Our team has not identified a manufacturer-published source of patient assistance information for EPKINLY.
Where can I find Epkinly prescribing information?
EPKINLY prescribing information can be found at the link below: Visit Here →
Where can I find Epkinly side effect information?
Information regarding EPKINLY's side effects can be found at MedlinePlus Visit Here →
Does billing EPKINLY require JZ/JW wastage modifiers?
CMS does not include EPKINLY (C9155) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing C9155. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.